drugset / Trial / NCT02127697
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will assess efficacy, safety and tolerability of NVA237 compared to placebo in patients with poorly controlled asthma over 52 weeks of treatment.
Timeline
- Start
- 2015-03
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | — | Inhaled |
| Background | Salbutamol | Unknown | — | — |